Leonard Florence Center For Living in Chelsea, MA

Leonard Florence Center For Living is a medicare and medicaid certified nursing home in Chelsea, Massachusetts. It is located in Suffolk county at 165 Captain's Row, Chelsea, Massachusetts 02150. You can reach out to the office of Leonard Florence Center For Living via phone at (617) 887-0001. This skilled nursing facility has 100 federally certified beds with average occupancy rate of 88.6%. Its legal business name is Chelsea Jewish Green House, Inc. and has the following ownership type - Non Profit - Corporation.

Leonard Florence Center For Living (Medicare CCN 225775) is certified by CMS (Centers for Medicare & Medicaid Services) and participates in both medicare and medicaid program. This means if you are part of medicare or medicaid program, you may consider this nursing facility for your medical needs. It was first certified by CMS in 2010 (14 years certified) and the last quality survey was conducted in October, 2019.

Contact Information

Leonard Florence Center For Living
165 Captain's Row, Chelsea, Massachusetts 02150
(617) 887-0001


Nursing Home Profile

NameLeonard Florence Center For Living
Location165 Captain's Row, Chelsea, Massachusetts
Certified ByMedicare and Medicaid
No. of Certified Beds100
Occupancy Rate88.6%
Medicare ID (CCN)225775
Legal Business NameChelsea Jewish Green House, Inc.
Ownership TypeNon Profit - Corporation

NPI Associated with this Nursing Home:

Nursing Homes may have multiple NPI numbers. We have found possible NPI number/s associated with Leonard Florence Center For Living from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number1336411727
Organization NameCHELSEA JEWISH GREEN HOUSE
Doing Business AsLEONARD FLORENCE CENTER FOR LIVING
Address165 Captains Row, Chelsea, MA 02150
Phone Number617-887-0001

News Archive

Acura Pharmaceuticals reports net loss of $3.2M for second-quarter 2010

Acura Pharmaceuticals, Inc. today reported a second quarter 2010 net loss of $3.2 million or $0.07 per share compared to net loss of $6.5 million, or $0.14 per share for the second quarter of 2009. For the six months ended June 30, 2010, the Company reported a net loss of $7.2 million, or $0.15 per share compared to net loss of $7.8 million, or $0.17 per share for the same period in 2009. At July 29, 2010 we had cash and cash equivalents of approximately $26.5 million with no term indebtedness.

Study: Caplacizumab not cost effective for treating thrombotic thrombocytopenic purpura

In a new study by Yale Cancer Center researchers, the drug caplacizumab is shown not to be cost-effective in treating thrombotic thrombocytopenic purpura (TTP) when added to the standard-of-care.

Individualized diets more effective in controlling blood glucose levels, study finds

An individualized diet based on a person's genetics, microbiome and lifestyle is more effective in controlling blood glucose (sugar) levels than one that considers only nutritional composition of food, Mayo Clinic researchers have confirmed.

Duke researchers track missing T-cells in glioblastoma patients

Glioblastoma brain tumors can have an unusual effect on the body's immune system, often causing a dramatic drop in the number of circulating T-cells that help drive the body's defenses.

Drug prevents onset of cognitive and cellular effects in mouse model of Alzheimer's disease

In a novel animal study design that mimicked human clinical trials, researchers at University of California, San Diego School of Medicine report that long-term treatment using a small molecule drug that reduces activity of the brain's stress circuitry significantly reduces Alzheimer's disease (AD) neuropathology and prevents onset of cognitive impairment in a mouse model of the neurodegenerative condition.

Read more Medical News

› Verified 7 days ago


NPI Number1689806937
Organization NameCHELSEA JEWISH GREEN HOUSE, INC
Doing Business AsLEONARD FLORENCE CENTER FOR LIVING
Address165 Captains Row, Chelsea, MA 02150
Phone Number617-887-0001

News Archive

Acura Pharmaceuticals reports net loss of $3.2M for second-quarter 2010

Acura Pharmaceuticals, Inc. today reported a second quarter 2010 net loss of $3.2 million or $0.07 per share compared to net loss of $6.5 million, or $0.14 per share for the second quarter of 2009. For the six months ended June 30, 2010, the Company reported a net loss of $7.2 million, or $0.15 per share compared to net loss of $7.8 million, or $0.17 per share for the same period in 2009. At July 29, 2010 we had cash and cash equivalents of approximately $26.5 million with no term indebtedness.

Study: Caplacizumab not cost effective for treating thrombotic thrombocytopenic purpura

In a new study by Yale Cancer Center researchers, the drug caplacizumab is shown not to be cost-effective in treating thrombotic thrombocytopenic purpura (TTP) when added to the standard-of-care.

Individualized diets more effective in controlling blood glucose levels, study finds

An individualized diet based on a person's genetics, microbiome and lifestyle is more effective in controlling blood glucose (sugar) levels than one that considers only nutritional composition of food, Mayo Clinic researchers have confirmed.

Duke researchers track missing T-cells in glioblastoma patients

Glioblastoma brain tumors can have an unusual effect on the body's immune system, often causing a dramatic drop in the number of circulating T-cells that help drive the body's defenses.

Drug prevents onset of cognitive and cellular effects in mouse model of Alzheimer's disease

In a novel animal study design that mimicked human clinical trials, researchers at University of California, San Diego School of Medicine report that long-term treatment using a small molecule drug that reduces activity of the brain's stress circuitry significantly reduces Alzheimer's disease (AD) neuropathology and prevents onset of cognitive impairment in a mouse model of the neurodegenerative condition.

Read more Medical News

› Verified 7 days ago

Quality Ratings:

Nursing homes vary in the quality of care and services they provide to their residents. The below quality ratings for Leonard Florence Center For Living are calculated from three sources - health inspection results, staffing data, and quality measure data. This information gives you an indication of the care Leonard Florence Center For Living give to their patients.
Ratings from Surveys (Inspections):
Ratings from Quality Measures:
Ratings from Staffing Data:
Overall Rating:

News Archive

Acura Pharmaceuticals reports net loss of $3.2M for second-quarter 2010

Acura Pharmaceuticals, Inc. today reported a second quarter 2010 net loss of $3.2 million or $0.07 per share compared to net loss of $6.5 million, or $0.14 per share for the second quarter of 2009. For the six months ended June 30, 2010, the Company reported a net loss of $7.2 million, or $0.15 per share compared to net loss of $7.8 million, or $0.17 per share for the same period in 2009. At July 29, 2010 we had cash and cash equivalents of approximately $26.5 million with no term indebtedness.

Study: Caplacizumab not cost effective for treating thrombotic thrombocytopenic purpura

In a new study by Yale Cancer Center researchers, the drug caplacizumab is shown not to be cost-effective in treating thrombotic thrombocytopenic purpura (TTP) when added to the standard-of-care.

Individualized diets more effective in controlling blood glucose levels, study finds

An individualized diet based on a person's genetics, microbiome and lifestyle is more effective in controlling blood glucose (sugar) levels than one that considers only nutritional composition of food, Mayo Clinic researchers have confirmed.

Duke researchers track missing T-cells in glioblastoma patients

Glioblastoma brain tumors can have an unusual effect on the body's immune system, often causing a dramatic drop in the number of circulating T-cells that help drive the body's defenses.

Drug prevents onset of cognitive and cellular effects in mouse model of Alzheimer's disease

In a novel animal study design that mimicked human clinical trials, researchers at University of California, San Diego School of Medicine report that long-term treatment using a small molecule drug that reduces activity of the brain's stress circuitry significantly reduces Alzheimer's disease (AD) neuropathology and prevents onset of cognitive impairment in a mouse model of the neurodegenerative condition.

Read more Medical News

› Verified 7 days ago

Complaints, Fines and Penalties:

Number of Facility Reported Incidents0
Number of Substantiated Complaints0
Number of Fines0
Total Amount of Fines in Dollars$0
Number of Payment Denials0
Total Number of Penalties0

Patients' Stay Experience:

The resident survey data of Leonard Florence Center For Living is compared against the national average with the color code indicators: Better than National Average Worse than National Average

Experience MeasureProviderNational Avg.
Percentage of long-stay residents whose need for help with daily activities has increased4.2314.46
Percentage of long-stay residents who lose too much weight8.335.51
Percentage of low risk long-stay residents who lose control of their bowels or bladder55.7748.41
Percentage of long-stay residents with a catheter inserted and left in their bladder0.41.79
Percentage of long-stay residents with a urinary tract infection0.392.65
Percentage of long-stay residents who have depressive symptoms0.775.05
Percentage of long-stay residents who were physically restrained00.23
Percentage of long-stay residents experiencing one or more falls with major injury2.93.36
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine90.2293.87
Percentage of long-stay residents who received an antipsychotic medication13.0614.2
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine98.6783.88
Percentage of short-stay residents who newly received an antipsychotic medication0.811.79
Percentage of long-stay residents whose ability to move independently worsened12.6617.09
Percentage of long-stay residents who received an antianxiety or hypnotic medication27.219.7
Percentage of high risk long-stay residents with pressure ulcers10.677.32
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine99.395.98
Percentage of short-stay residents who made improvements in function90.5167.99
Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine98.5982.93

News Archive

Acura Pharmaceuticals reports net loss of $3.2M for second-quarter 2010

Acura Pharmaceuticals, Inc. today reported a second quarter 2010 net loss of $3.2 million or $0.07 per share compared to net loss of $6.5 million, or $0.14 per share for the second quarter of 2009. For the six months ended June 30, 2010, the Company reported a net loss of $7.2 million, or $0.15 per share compared to net loss of $7.8 million, or $0.17 per share for the same period in 2009. At July 29, 2010 we had cash and cash equivalents of approximately $26.5 million with no term indebtedness.

Study: Caplacizumab not cost effective for treating thrombotic thrombocytopenic purpura

In a new study by Yale Cancer Center researchers, the drug caplacizumab is shown not to be cost-effective in treating thrombotic thrombocytopenic purpura (TTP) when added to the standard-of-care.

Individualized diets more effective in controlling blood glucose levels, study finds

An individualized diet based on a person's genetics, microbiome and lifestyle is more effective in controlling blood glucose (sugar) levels than one that considers only nutritional composition of food, Mayo Clinic researchers have confirmed.

Duke researchers track missing T-cells in glioblastoma patients

Glioblastoma brain tumors can have an unusual effect on the body's immune system, often causing a dramatic drop in the number of circulating T-cells that help drive the body's defenses.

Drug prevents onset of cognitive and cellular effects in mouse model of Alzheimer's disease

In a novel animal study design that mimicked human clinical trials, researchers at University of California, San Diego School of Medicine report that long-term treatment using a small molecule drug that reduces activity of the brain's stress circuitry significantly reduces Alzheimer's disease (AD) neuropathology and prevents onset of cognitive impairment in a mouse model of the neurodegenerative condition.

Read more News

› Verified 7 days ago


Nursing Homes in Chelsea, MA

Soldiers Home In Massachusetts
Location: 91 Crest Avenue, Chelsea, Massachusetts 02150
Phone: (617) 884-5660    
Katzman Family Center For Living
Location: 17 Lafayette Avenue, Chelsea, Massachusetts 02150
Phone: (617) 884-6766    
Eastpointe Rehab Center
Location: 255 Central Avenue, Chelsea, Massachusetts 02150
Phone: (617) 884-5700    
Leonard Florence Center For Living
Location: 165 Captain's Row, Chelsea, Massachusetts 02150
Phone: (617) 887-0001    

Nursing Home

A nursing home (also called skilled nursing facility) is a facility or distinct part of an institution whose primary function is to provide medical, continuous nursing, and other health and social services to patients who are not in an acute phase of illness requiring services in a hospital, but who require primary restorative or skilled nursing services on an inpatient basis above the level of intermediate or custodial care in order to reach a degree of body functioning to permit self care in essential daily living.

A skilled nursing facility (SNF) may be a freestanding facility or part of a hospital that has been certified by Medicare to admit patients requiring subacute care and rehabilitation.

Nursing Home Compare

Nursing Home Compare allows consumers to compare information about nursing homes. It contains quality of care and staffing information for all 15,000 plus Medicare- and Medicaid-participating nursing homes.

Note: Nursing homes aren't included on Nursing Home Compare if they aren't Medicare or Medicaid certified. These Nursing Homes can be licensed by the state.

Information on Nursing Home Compare isn't an endorsement or advertisement for any nursing home and should be considered carefully. Use it with other information you gather about nursing homes facilities. Talk to your doctor or other health care provider about the information on Nursing Home Compare.

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.